Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting

BackgroundNicotinamide adenine dinucleotide (NAD+) is a cofactor for NAD+-dependent enzymes that regulate DNA repair, cellular metabolism, and immune function. Supplementation with NAD+ and its precursors is commonly used to prevent age-related disease and extend healthspan. Commercial clinical and...

Повний опис

Бібліографічні деталі

Автори:	Kirsten Reyna, Greer Heinzen, Nikita Patel, Marie Ritter, Alexandra Siojo, Henry Legere, Rachele Pojednic
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2026-02-01
Серія:	Frontiers in Aging
Предмети:	biomarkers Intravenous NAD+ nicotinamide adenine Dinucleotide nicotinamide Riboside safety
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fragi.2026.1652582/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!